Massachusetts Statutes

§ 47L — Off-label drug use; cancer; review panel

Massachusetts § 47L
JurisdictionMassachusetts
Part IADMINISTRATION OF THE GOVERNMENT
Title XXIICORPORATIONS
Ch. 175INSURANCE

This text of Massachusetts § 47L (Off-label drug use; cancer; review panel) is published on Counsel Stack Legal Research, covering Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mass. Gen. Laws ch. 175, § 47L (2026).

Text

Section 47L. The commissioner shall establish a panel of six medical experts to review off-label uses, so-called, for prescription drugs for the treatment of cancer not included in any of the standard reference compendia or in the medical literature and to advise said commissioner in such instances whether a particular off-label use is medically appropriate. The panel shall make such recommendations from time to time and whenever a particular dispute about payment for such off-label use is referred to the panel by the commissioner. The members of said panel shall include:

(a)three medical oncologists selected by the state medical oncology association, (b) a physician selected by the Massachusetts medical association, (c) a physician selected by a hospital and medical service corporation

Free access — add to your briefcase to read the full text and ask questions with AI

Nearby Sections

15
View on official source ↗

Cite This Page — Counsel Stack

Bluebook (online)
Massachusetts § 47L, Counsel Stack Legal Research, https://law.counselstack.com/statute/ma/175/47L.